Episode Details
Back to Episodes
Medicare GLP-1 Bridge: 50 Dollar Access | Business and Finance News
Description
Starting July 1st, Medicare’s new GLP-1 Bridge pilot program lets millions of seniors access Wegovy and Zepbound for weight loss at just $50 a month — a huge drop from typical costs. Unlike past rules, these drugs are now covered solely for weight loss, not just for diabetes or heart disease. The flat fee doesn’t count toward deductibles or out-of-pocket limits, and the program runs until December 31, 2027. Eligibility requires a BMI-based prescription plus conditions like prediabetes or hypertension — but not if you’re already using GLP-1s for other covered illnesses. Doctors must verify eligibility, and prior authorization may be needed. This is your chance to get life-changing weight-loss treatment without breaking the bank.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/a7bbb6a2ce889a3a